Cargando…

Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia

BACKGROUND: For individuals managing diabetes, the administration of glucagon for severe hypoglycemia can be lifesaving, yet, until recently, there were no easy-to-use devices for these stressful emergencies. New products have emerged to meet this need, including nasal glucagon (NG) and auto-injecto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajpai, Sanjay K, Cambron-Mellott, M Janelle, Will, Oliver, Poon, Jiat-Ling, Wang, Qianqian, Mitchell, Beth D, Peck, Eugenia Y, Babrowicz, Jane, Raibulet, Nedina K, Child, Christopher J, Beusterien, Kathleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694976/ https://www.ncbi.nlm.nih.gov/pubmed/36439296 http://dx.doi.org/10.2147/DMSO.S367010

Ejemplares similares

Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation
por: Valentine, Virginia, et al.
Publicado: (2019)

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment
por: Kumar, Jinender, et al.
Publicado: (2021)

A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia
por: Bailey, Naila Celeste, et al.
Publicado: (2022)

Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
por: Osumili, Beatrice, et al.
Publicado: (2022)

Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies
por: Christiansen, Mark P, et al.
Publicado: (2021)

Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional Study
por: Kelly, Caitlin S., et al.
Publicado: (2023)

Evaluating Ease of Use and Patient Safety of Dasiglucagon Hypo Pal Autoinjector for the Management of Hypoglycemia
por: Schaumleffel, Carol
Publicado: (2023)

Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study
por: Escalada, Javier, et al.
Publicado: (2020)

Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment
por: Cambron-Mellott, M Janelle, et al.
Publicado: (2021)

Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study
por: Yale, Jean-François, et al.
Publicado: (2017)

The clinical, economic, and patient‐centric burden of insomnia symptom severity in adults with major depressive disorder in the United States
por: Joshi, Kruti, et al.
Publicado: (2023)

Comparison of drug delivery with autoinjector versus manual prefilled syringe and between three different autoinjector devices administered in pig thigh
por: Hill, Robert L, et al.
Publicado: (2016)

Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia
por: Pontiroli, Antonio E., et al.
Publicado: (2019)

The pharmacokinetics of epinephrine/adrenaline autoinjectors
por: Dreborg, Sten, et al.
Publicado: (2021)

Leveraging Dissolution by Autoinjector Designs
por: Spangardt, Christoph, et al.
Publicado: (2022)

Conversations and Reactions Around Severe Hypoglycemia (CRASH) Study: Results From People With Diabetes and Caregivers in the United States
por: Snoek, Frank J., et al.
Publicado: (2022)

Development and validation of fear of hypoglycemia screener: results from the T1D exchange registry
por: Liu, Jingwen, et al.
Publicado: (2023)

Accidental Digital Ischemia by an Epinephrine Autoinjector
por: Nayaz, Mohamed, et al.
Publicado: (2023)

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes
por: Siafarikas, Aris, et al.
Publicado: (2012)

New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions
por: La Sala, Lucia, et al.
Publicado: (2021)

Factors associated with patient activation among individuals with depression within racial/ethnic groups in the United States
por: Janelle Cambron-Mellott, M., et al.
Publicado: (2023)

Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
por: Kedia, Nitil
Publicado: (2011)

Adherence with epinephrine autoinjector prescriptions in primary care
por: Abrams, Elissa M., et al.
Publicado: (2017)

Development of an advanced injection time model for an autoinjector
por: Thueer, Thomas, et al.
Publicado: (2018)

Adherence to adrenaline autoinjector prescriptions in patients with anaphylaxis
por: Parke, Louise, et al.
Publicado: (2019)

Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes
por: Dribin, Timothy E., et al.
Publicado: (2023)

Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors
por: Barone, Donald A., et al.
Publicado: (2016)

Use of glucagon in severe hypoglycemia is scarce in most countries, and has not been expanded by new ready-to-use glucagons
por: Pontiroli, Antonio E., et al.
Publicado: (2022)

A Potential Role for Endogenous Glucagon in Preventing Post-Bariatric Hypoglycemia
por: Lobato, Carolina B., et al.
Publicado: (2020)

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries
por: Cambron-Mellott, M. Janelle, et al.
Publicado: (2022)

Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey
por: Ross, Amy Perrin, et al.
Publicado: (2023)

Bioequivalence evaluation of epinephrine autoinjectors with attention to rapid delivery
por: Sclar, David Alexander
Publicado: (2013)

Autoinjectors Preferred for Intramuscular Epinephrine in Anaphylaxis and Allergic Reactions
por: Campbell, Ronna L., et al.
Publicado: (2016)

Accidental self-administration of an epinephrine autoinjector by a toddler
por: Edgerley, Sarah, et al.
Publicado: (2021)

Are adrenaline autoinjectors fit for purpose? A pilot study of the mechanical and injection performance characteristics of a cartridge-versus a syringe-based autoinjector
por: Schwirtz, Andreas, et al.
Publicado: (2010)

Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States
por: Bajpai, Sanjay, et al.
Publicado: (2021)

Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
por: Gelhorn, Heather L, et al.
Publicado: (2016)

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia()
por: Chabenne, Joseph, et al.
Publicado: (2014)

Mitochondrial GTP Insensitivity Contributes to Hypoglycemia in Hyperinsulinemia Hyperammonemia by Inhibiting Glucagon Release
por: Kibbey, Richard G., et al.
Publicado: (2014)

Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Hypoglycemia
por: Ja’arah, Daria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fkus8udp2tv4cl9i235241o0gb